CSL has dedicated the past 100 years to protecting the health of Australians and of those around the world, delivering innovative medicines to patients that need them in order to save and improve lives. We are proud to have played a pivotal role in researching medical and scientific unknowns, to become the global leader in biotherapeutics that we are today.
The key to us being able to do this has been collaboration throughout all parts of our business; with patients and patient groups, clinicians and research collaborations with medical research institutions, universities and hospitals. Strong and productive collaborations are key for both scientific discoveries and for developing those ideas into new medicines for patients. And they have been at the heart of CSL’s success.
In 1944, we delivered penicillin to our nation. Responding to the discoveries made by Dr Howard Florey’s team in Oxford, CSL was able to manufacture and supply penicillin to the Australian forces involved in World War II by February 1944, and using our production capacity, Australia was the first country in the world to supply penicillin to its civilian population. Similarly, CSL has played a vital role in researching developing and supplying many important vaccines and plasma therapies.
None of these achievements would have been possible without long-term partnerships. When Walter and Elizabeth Hall Institute of Medical Research (WEHI) offered rent free accommodation in 1917, little did we know that this would be the beginning of a long-term collaboration that would still see us working together 100 years later.
We worked with the Red Cross during the 1950s to build the solid foundations that still underpin the collection and production of human plasma products to save Australian lives. The supply chain and systems that we created together to provide plasma protein therapies to Australian patients from plasma collected by the Red Cross is a system that still operates today.
Partnerships have allowed us to be versatile as research and development continues to grow. August 2016 marks the 10 year anniversary since the global launch of Gardasil, the Australian-discovered HPV/cervical cancer vaccine. CSL and the University of Queensland began a partnership to develop this vaccine back in 1991 and more than 170 million doses have been administered worldwide to date.
100 years of success, and we’re just getting started
CSL will continue to develop and manufacture products that will prevent serious medical conditions across the world. We are invested in research and development and forgingpartnerships across the medical research community to complement our in-house expertise and deliver world class research programs.